DBV Technologies | Attività



Assets Cambiamento Data
Acadia Pharmaceuticals USD 1.23B 93.19M 2025-06
Alnylam Pharmaceuticals USD 4.57B 352.21M 2025-06
Amarin USD 655.68M 29.67M 2025-03
BioMarin Pharmaceutical USD 7.46B 309.33M 2025-06
DBV Technologies USD 50.56M 15.1M 2025-03
Halozyme Therapeutics USD 2.05B 142.63M 2025-06
Incyte USD 5.82B 71.99M 2025-06
Insmed USD 2.48B 677.12M 2025-06
Ionis Pharmaceuticals USD 2.99B 172.18M 2025-06
Neurocrine Biosciences USD 3.89B 202.1M 2025-06
PTC Therapeutics USD 2.63B 21.23M 2025-06
Sarepta Therapeutics USD 3.68B 214.43M 2025-06
Ultragenyx Pharmaceutical USD 1.31B 5.66M 2025-06
United Therapeutics USD 7.91B 164.1M 2025-06


DBV Technologies Attività - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.